4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0001062993-22-000242
Options or other derivatives
- Director acquired 12,767 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
KAPLAN GILLA · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-12-31 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +12,767 | 12,767 | D |
Loading xslF345X03/form4.xml…